At Huntsman Cancer Institute, you receive comprehensive, multidisciplinary care for soft-tissue sarcomas. Our Sarcoma Care Team provides personalized and compassionate care at every step, from ...
For most types of STS and for earlier stages of sarcoma, the treatment is usually similar. People may have surgery alone, or radiation therapy or chemotherapy in addition to surgery. Treatment may ...
Soft tissue sarcomas are a rare group of cancers that develop in soft tissue. They can develop almost anywhere in your body, including in your hip, thigh, and groin. Soft tissue sarcomas are rare ...
An Era of Advances in Systemic Therapies for Advanced Thyroid Cancer Soft tissue sarcomas (STS) of the extremity and trunk are heterogeneous and rare tumors that require coordinated multidisciplinary ...
Soft tissue sarcoma recovery extends beyond physical healing, emphasizing social engagement and emotional well-being for improved quality of life. Pain and daily activity participation are major ...
Soft tissue sarcomas are cancers that develop in your body’s soft tissues like muscle, fat, tendons, or cartilage. Your legs are the most common place they develop. The American Cancer Society ...
Soft tissue sarcomas are rare solid tumors that are being increasingly classified and treated by subtype. Approximately 12,020 people will be diagnosed with a soft tissue sarcoma in the United States ...
Patients with non-metastatic soft tissue sarcoma (STS) who need pre-operative radiation therapy can safely receive hypofractionated treatment over three weeks instead of five, with comparable tumor ...
A phase II study of gimatecan as salvage treatment in patients with advanced or metastatic soft tissue sarcoma (STS) relapsing after anthracycline / ifosfamide - based chemotherapy regimens No ...
Please provide your email address to receive an email when new articles are posted on . BOSTON — Excisional biopsies of soft tissue sarcoma of the hand are associated with more positive margins and a ...
Adding a PD-1 inhibitor to standard of care improved disease-free survival (DFS) in stage III soft-tissue sarcoma of the extremity, a randomized trial showed. In patients with mostly undifferentiated ...
Novel biomarkers like GDF15 and OPN show promise in diagnosing and prognosticating uterine sarcoma, potentially enabling early identification and tailored therapy. Blood-based markers such as NLR and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results